History | Eptinezumab for preventing migraine | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 158 KB)

Published:

01 March 2023

Final draft guidance

Final draft guidance
Final appraisal document (PDF 166 KB)

Published:

25 January 2023
Committee papers (PDF 4.65 MB)

Published:

25 January 2023

Invitation to participate

Final scope (PDF 190 KB)

Published:

16 June 2022
Equality impact assessment (Scoping) (PDF 122 KB)

Published:

16 June 2022
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 350 KB)

Published:

16 June 2022
Final stakeholder list (PDF 158 KB)

Published:

16 June 2022

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 206 KB)

Published:

27 January 2022
Draft matrix post referral (PDF 158 KB)

Published:

27 January 2022